Literature DB >> 8453258

Weight loss in patients with hematological neoplasias is associated with immune system stimulation.

H Denz1, B Orth, G Weiss, R Herrmann, P Huber, H Wachter, D Fuchs.   

Abstract

Weight loss is the main symptom of so-called tumor cachexia. The pathogenetic mechanisms underlying cachexia are poorly understood; however, it appears that enhanced formation of cytokines such as interferon-gamma and tumor necrosis factor-alpha are involved. In 94 patients suffering from hematological neoplasias we compared body weight changes with serum neopterin, tryptophan, and kynurenine. Biochemical changes, the formation of neopterin, the degradation of tryptophan are closely related to interferon-gamma activity. The majority of our patients had increased neopterin and decreased tryptophan concentrations. Weight loss was seen particularly in patients with higher neopterin and lower tryptophan values. An association between higher neopterin levels and greater weight loss was apparent at study entry and during the follow-up of patients. Our data support the concept that weight loss is closely linked to endogenous interferon-gamma activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453258     DOI: 10.1007/bf00210961

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  21 in total

Review 1.  Haemopoietic growth factors 1.

Authors:  D Metcalf
Journal:  Lancet       Date:  1989-04-15       Impact factor: 79.321

2.  T cell-monocyte interactions in the production of humoral factors regulating human granulopoiesis in vitro.

Authors:  F Herrmann; S A Cannistra; J D Griffin
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

3.  Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.

Authors:  B Klein; X G Zhang; M Jourdan; J Content; F Houssiau; L Aarden; M Piechaczyk; R Bataille
Journal:  Blood       Date:  1989-02       Impact factor: 22.113

4.  Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients.

Authors:  S C Wright; A Jewett; R Mitsuyasu; B Bonavida
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

5.  Human macrophages degrade tryptophan upon induction by interferon-gamma.

Authors:  E R Werner; G Bitterlich; D Fuchs; A Hausen; G Reibnegger; G Szabo; M P Dierich; H Wachter
Journal:  Life Sci       Date:  1987-07-20       Impact factor: 5.037

6.  Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells.

Authors:  P Matthys; R Dijkmans; P Proost; J Van Damme; H Heremans; H Sobis; A Billiau
Journal:  Int J Cancer       Date:  1991-08-19       Impact factor: 7.396

7.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

8.  Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines.

Authors:  L L Moldawer; C Andersson; J Gelin; K G Lundholm
Journal:  Am J Physiol       Date:  1988-03

9.  Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells.

Authors:  G Werner-Felmayer; E R Werner; D Fuchs; A Hausen; G Reibnegger; H Wachter
Journal:  Biol Chem Hoppe Seyler       Date:  1989-09

10.  Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.

Authors:  K J Tracey; H Wei; K R Manogue; Y Fong; D G Hesse; H T Nguyen; G C Kuo; B Beutler; R S Cotran; A Cerami
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  10 in total

1.  Kynurenine pathway metabolites in humans: disease and healthy States.

Authors:  Yiquan Chen; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2009-01-08

2.  Diminished quality of life in patients with cancer correlates with tryptophan degradation.

Authors:  Katharina Schroecksnadel; Michael Fiegl; Karin Prassl; Christiana Winkler; Hubert A Denz; Dietmar Fuchs
Journal:  J Cancer Res Clin Oncol       Date:  2007-03-14       Impact factor: 4.553

3.  Increased serum concentrations of soluble tumor necrosis factor receptor I in noncachectic and cachectic patients with advanced gastric and colorectal cancer.

Authors:  M Shibata; M Takekawa; S Amano
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

Review 4.  Anaemia of cancer: an overview of mechanisms involved in its pathogenesis.

Authors:  H Z W Grotto
Journal:  Med Oncol       Date:  2007-09-02       Impact factor: 3.064

5.  Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown.

Authors:  Katharina Kurz; Michael Fiegl; Bernhard Holzner; Johannes Giesinger; Marianna Pircher; Guenter Weiss; Hubert A Denz; Dietmar Fuchs
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

6.  Low plasma tryptophan is associated with olfactory function in healthy elderly community dwellers in Japan.

Authors:  Yusuke Adachi; Yoshiki Shimodaira; Hidehiro Nakamura; Akira Imaizumi; Maiko Mori; Yoko Kageyama; Yasushi Noguchi; Asuka Seki; Yuki Okabe; Yuko Miyake; Kaori Ono; Shu Kumagai
Journal:  BMC Geriatr       Date:  2017-10-16       Impact factor: 3.921

7.  Biomarkers related to fatty acid oxidative capacity are predictive for continued weight loss in cachectic cancer patients.

Authors:  Silvia Catanese; Carl Friedrich Beuchel; Teresa Sawall; Florian Lordick; Rommy Brauer; Markus Scholz; Uta Ceglarek; Ulrich T Hacker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-10-11       Impact factor: 12.910

8.  Multi-omics analysis reveals the host-microbe interactions in aged rhesus macaques.

Authors:  Jue Xu; Yue Lan; Xinqi Wang; Ke Shang; Xu Liu; Jiao Wang; Jing Li; Bisong Yue; Meiying Shao; Zhenxin Fan
Journal:  Front Microbiol       Date:  2022-09-27       Impact factor: 6.064

9.  Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer.

Authors:  A Huang; D Fuchs; B Widner; C Glover; D C Henderson; T G Allen-Mersh
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

Review 10.  Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer.

Authors:  Lukas Lanser; Patricia Kink; Eva Maria Egger; Wolfgang Willenbacher; Dietmar Fuchs; Guenter Weiss; Katharina Kurz
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.